Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
3.20 INR
10.13 B INR
152.11 B INR
526.25 M
About Biocon Limited
Sector
Industry
CEO
Siddharth Mittal
Website
Headquarters
Bangalore
Founded
1978
ISIN
INE376G01013
FIGI
BBG000BJHC64
Biocon Ltd. is a holding company, which engages in the manufacture, research, and development of therapeutic drugs. It operates through the following segments: Small Molecules, Biologics, Branded Formulations, and Research Services. The Small Molecules segment manufactures spanning statins, immunosuppressants, antifungals, anti-obesity, anti-diabetics, ophthalmologicals, oncologicals, and urologicals etc. The Biologics segment provides Insulins and Analogs, biosimilar Monoclonal Antibodies (MAbs), and recombinant proteins The Branded Formulation segment consists of therapeutic areas of diabetology, oncology, immunology and critical care. The Research Services segment covers Syngene development platforms. The company was founded by Kiran Mazumdar-Shaw on November 29, 1978 and is headquartered in Bangalore, India.
Related stocks
“Biocon Showing Strength — Support Zone Intact!Biocon Technical Update (Daily Timeframe)
Biocon is holding a strong support zone around ₹330–340, which is being respected across multiple timeframe structures. Within the stock, a smaller parallel channel is forming, whose support also aligns with the ₹330–340 range.
The mid-boundary of this sho
BIOCON:Support Zone Holding Firm – Eyes on Next Upside MoveBIOCON – Daily Timeframe Analysis
Support Respect: BIOCON is currently respecting its 2023 support zone.
Current Level: The stock is trading near the 320–330 range.
Next Support: If this zone breaks, the next major support is placed around 285.
Bullish Scenario: Sustaining above these key suppor
BIOCON Ltd for 18th Sept #BIOCON BIOCON Ltd for 18th Sept #BIOCON
Resistance 360 Watching above 361 for upside momentum.
Support area 350 Below 355 gnoring upside momentum for intraday
Watching below 349 for downside movement...
Above 355 ignoring downside move for intraday
Charts for Educational purposes only.
Please follow st
Global Private Equity Trends1. Introduction
Private equity (PE) has emerged as one of the most powerful forces in global finance. Over the last four decades, it has transformed from a niche investment strategy practiced by a handful of firms into a multi-trillion-dollar asset class that shapes industries, creates jobs, restru
Role of Institutional Investors in Global MarketsIntroduction
Global financial markets are vast ecosystems where millions of buyers and sellers engage daily in the exchange of assets, ranging from stocks and bonds to currencies, commodities, and derivatives. While individual retail investors make up an important component of these markets, the re
Sustainable FinanceIntroduction
The 21st century has brought not only unprecedented technological growth and globalization but also serious challenges related to climate change, resource depletion, social inequality, and corporate governance failures. In this new era, finance is no longer just about maximizing profit
Geopolitical Risks & Global EventsIntroduction
In today’s interconnected world, financial markets, economies, and even societies are more linked than ever before. A conflict in one part of the globe, a trade dispute between two large economies, or even a natural disaster can ripple across continents within hours. This interconnecte
Biocon: Heading for All-Time High?🚀 Biocon: Heading for All-Time High? 🚀
📉 CMP: ₹390
🔒 Stop Loss: ₹330
🎯 Targets: ₹428 | ₹478 | ₹560
🔍 Why Biocon Looks Promising?
✅ Weekly Rounding Bottom Breakout: Breakout triggered above ₹390
✅ Weekly Box Breakout: Confirmation above ₹398 strengthens the setup
✅ Final Confirmation: A weekly clo
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
PHARMABEES
Nippon India Nifty Pharma ETF Units Exchange Traded FundWeight
2.64%
Market value
2.94 M
USD
Explore more ETFs
Frequently Asked Questions
The current price of BIOCON is 380.40 INR — it has decreased by −1.25% in the past 24 hours. Watch Biocon Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange Biocon Limited stocks are traded under the ticker BIOCON.
BIOCON stock has risen by 0.63% compared to the previous week, the month change is a 9.66% rise, over the last year Biocon Limited has showed a 17.44% increase.
We've gathered analysts' opinions on Biocon Limited future price: according to them, BIOCON price has a max estimate of 465.00 INR and a min estimate of 270.00 INR. Watch BIOCON chart and read a more detailed Biocon Limited stock forecast: see what analysts think of Biocon Limited and suggest that you do with its stocks.
BIOCON reached its all-time high on Dec 23, 2020 with the price of 487.75 INR, and its all-time low was 14.15 INR and was reached on Dec 2, 2008. View more price dynamics on BIOCON chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
BIOCON stock is 2.41% volatile and has beta coefficient of 1.06. Track Biocon Limited stock price on the chart and check out the list of the most volatile stocks — is Biocon Limited there?
Today Biocon Limited has the market capitalization of 508.25 B, it has increased by 2.68% over the last week.
Yes, you can track Biocon Limited financials in yearly and quarterly reports right on TradingView.
Biocon Limited is going to release the next earnings report on Nov 11, 2025. Keep track of upcoming events with our Earnings Calendar.
BIOCON earnings for the last quarter are 0.26 INR per share, whereas the estimation was 0.71 INR resulting in a −63.48% surprise. The estimated earnings for the next quarter are 0.75 INR per share. See more details about Biocon Limited earnings.
Biocon Limited revenue for the last quarter amounts to 39.42 B INR, despite the estimated figure of 39.78 B INR. In the next quarter, revenue is expected to reach 41.75 B INR.
BIOCON net income for the last quarter is 314.00 M INR, while the quarter before that showed 3.44 B INR of net income which accounts for −90.89% change. Track more Biocon Limited financial stats to get the full picture.
Yes, BIOCON dividends are paid annually. The last dividend per share was 0.50 INR. As of today, Dividend Yield (TTM)% is 0.13%. Tracking Biocon Limited dividends might help you take more informed decisions.
Biocon Limited dividend yield was 0.15% in 2024, and payout ratio reached 5.91%. The year before the numbers were 0.19% and 5.85% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Biocon Limited EBITDA is 32.64 B INR, and current EBITDA margin is 21.93%. See more stats in Biocon Limited financial statements.
Like other stocks, BIOCON shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Biocon Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Biocon Limited technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Biocon Limited stock shows the strong buy signal. See more of Biocon Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.









